血管生成素樣蛋白2(ANGPTL2)多克隆抗體
Polyclonal Antibody to Angiopoietin Like Protein 2 (ANGPTL2)
HARP; ARP2; Angiopoietin-Related Protein 2
- 編號PAB919Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPB919Mu01-血管生成素樣蛋白2(ANGPTL2)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.5mg/ml
- 且適物種Homo sapiens (Human，人), Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 616 ¥ 1436 ¥ 2052 ¥ 5130 ¥ 20520
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Mouse Colon Tissue; Primary Ab: 10μg/ml Rabbit Anti-Mouse ANGPTL2 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
Figure. DAB staining on IHC-P;
Samples: Mouse Brain Tissue. -
Figure. DAB staining on IHC-P;
Samples: Mouse Kidney Tissue. -
Figure. DAB staining on IHC-P;
Samples: Mouse Stomach Tissue.
-
Figure. Western Blot; Sample: Recombinant ANGPTL2, Mouse.
-
Figure. Western Blot; Sample: Human Serum.
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對ANGPTL2的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別ANGPTL2。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB919Mu02 | 血管生成素樣蛋白2(ANGPTL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB919Mu01 | 血管生成素樣蛋白2(ANGPTL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB919Mu01 | 血管生成素樣蛋白2(ANGPTL2)多克隆抗體 | WB; IHC |
| PAB919Mu02 | 血管生成素樣蛋白2(ANGPTL2)多克隆抗體 | WB; IHC; ICC; IP. |
| SEB919Mu | 血管生成素樣蛋白2(ANGPTL2)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB919Mu | 血管生成素樣蛋白2(ANGPTL2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Molecular and Cellular Endocrinology | Tumor necrosis factor-α increases angiopoietin-like protein 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes [PubMed: 21501655] |
| Journal of Leukocyte Biology | Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions [Pubmed:24626957] |
| J Am Heart Assoc. | Lack of Angiopoietin‐Like‐2 Expression Limits the Metabolic Stress Induced by a High‐Fat Diet and Maintains Endothelial Function in Mice [Pubmed:25128474] |
| Clinical Cancer Research | Elevated Serum Angiopoietin-like Protein 2 Correlates with the Metastatic Properties of Colorectal Cancer: A Serum Biomarker for Early Diagnosis and Recurrence [Pubmed:25294915] |
| Carcinogenesis | Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients [PubMed: 26420253] |
| Diabetologia | ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. [pubmed:27491833] |
| Stem Cell Research and Therapy | c-kit Positive Cardiac Outgrowth Cells Demonstrate Better Ability for Cardiac Recovery Against Ischemic Myopathy. [pubmed:29238626] |
| Cardiovasc Diabetol | Influence of micro-and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2?… [Pubmed:29879997] |
| Biomedical Reports | Circulating angiopoietin?like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease [] |
| Diabetologia | Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French … [Pubmed: 32040670] |
